A Practice Note discussing Subtitle F of the Coronavirus Aid, Relief, and Economic Security Act (CARES Act), which significantly reforms the US Food and Drug Administration's (FDA) framework for regulating over-the-counter (OTC) monograph drugs by implementing a new administrative order process, user fees, opportunities for market exclusivity, and other changes.